by Adaobi Ezeokoli | Sep 5, 2024 | Health Law & Policy, Commentary
A presidential election year puts a spotlight on the major parties’ health policies, and this year is no different. Vice President Kamala Harris, the Democratic candidate for president, has touted the last four years of accomplishments under the Biden Administration...
by Adaobi Ezeokoli | Aug 14, 2024 | Health Law & Policy, Commentary
State Medicaid programs are at the tail end of an unprecedented reduction in Medicaid enrollment. States are reinstituting normal Medicaid redetermination and renewal processes, which were paused during the height of the COVID-19 pandemic. Because of the pandemic...
by Adaobi Ezeokoli | Aug 1, 2024 | Health Law & Policy, Commentary
Last month, in between issuing decisions about mifepristone, EMTALA, Chevron deference, and presidential immunity, the Supreme Court of the United States also agreed to review a case that could upend transgender access to health care: U.S. v. Skrmetti. In the coming...
by Adaobi Ezeokoli | Jul 17, 2024 | Health Law & Policy, Commentary
The last days of the Supreme Court of the United States’ (SCOTUS) term brought some blockbuster decisions with far reaching implications for federal agencies charged with regulating health care. In an expected but still monumental move, SCOTUS issued a decision in...
by Adaobi Ezeokoli | Jul 2, 2024 | Health Law & Policy, Commentary
As the Supreme Court of the United States (SCOTUS) wrapped up its term, decisions came fast and furiously last week. On June 27, SCOTUS issued its decision on two consolidated cases, Moyle vs. United States and Idaho vs. United States (referred to as “Moyle”...
by Adaobi Ezeokoli | Jun 24, 2024 | Health Law & Policy
Last week, the U.S. Court of Appeals for the Fifth Circuit issued its much-anticipated decision inBraidwood v. Becerra, a case challenging the constitutionality of the ACA preventive care mandate. The mandate, discussed in more detail in a recent Health Care in...
by Adaobi Ezeokoli | Jun 20, 2024 | Health Law & Policy, Commentary
The Supreme Court of the United States’ term is wrapping up this month, and, as is custom, they are announcing the decisions in their most controversial cases at the end. The much-anticipated decision on access to mifepristone – a drug that in combination with another...
by Adaobi Ezeokoli | Jun 5, 2024 | Health Law & Policy, Commentary
People leaving incarceration often face a host of health challenges, including high rates of chronic physical and behavioral health conditions, barriers to coverage, and health-related social needs. Of particular concern, during the period following release, this...
by Adaobi Ezeokoli | May 22, 2024 | Health Law & Policy, Commentary
At the end of the last open enrollment period, Affordable Care Act (ACA) marketplace sign-ups were at an all-time high, with over 21 million people choosing a plan. This exceeded last year’s sign-ups (which were also a record high) by 5 million. These unprecedented...
by Adaobi Ezeokoli | May 8, 2024 | Health Law & Policy, Commentary
After a lengthy advocacy battle, the Biden Administration released a final rule last week extending eligibility for Affordable Care Act (ACA) coverage to people enrolled in the Deferred Action for Childhood Arrivals (DACA) program, also known as DACA recipients. Read...
by Adaobi Ezeokoli | May 2, 2024 | Health Law & Policy, Commentary
At long last, the Biden Administration has finalized its rule clarifying the protections laid out in Section 1557 of the Affordable Care Act (ACA), the part of the law that forbids federally funded health care activities and programs from discriminating on the basis...
by Adaobi Ezeokoli | Apr 25, 2024 | Health Law & Policy, News
On April 22, 2024, the Administration released a final rule strengthening privacy and confidentiality protections for reproductive health data under the federal Health Insurance Portability and Accountability Act (HIPAA). This rule is one of the many actions the...
